New cancer vaccine Modi-1 enters human trials for four tumor types
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new vaccine called Modi-1, designed to train the immune system to attack cancer cells. It is given as a tiny shot into the skin using a special microneedle device. The trial includes 168 people with advanced triple-negative breast cancer, head and neck cancer, …
Phase: PHASE1, PHASE2 • Sponsor: Scancell Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 18:32 UTC